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INTRODUCTION: Bone tissue engineering offers an alternative solution to the 
traditional methods of bone replacement including allografts and autografts [1]. Although 
these biological materials possess good osteoinductive and osteoconductive properties, 
both of them have limitations in terms of the availability, donor site morbidity and the 
risk of disease transmission with the use of allografts [2]. Therefore, the use of synthetic 
scaffold is the most common technique and good approach to regenerate diseased or 
damaged bone tissue. An ideal bone substitute should possess certain properties including 
osteoconductivity, biodegradability as well as adequate mechanical properties. Scaffold 
made of ceramic such as calcium phosphate and calcium sulphate is the most commonly 
used material for bone regeneration due to its bioactive properties. However, its 
brittleness and fast resorption rate are concerned clinically. Polycaprolactone (PCL), a 
kind of FDA approved biodegradable polymer, is another type of potential bone graft 
substitutes. However, the low mechanical strength and intrinsic hydrophobic properties of 
this bio-degradable polymer may limit its use in orthopaedics. Hence, modification is 
warranted in order to improve its mechanical and biological properties. Magnesium is a 
potential additive, as particular amount of magnesium ions may up-regulate the 
osteogenic markers and promote new bone formation in our previous studies [3]. In this 
study, our group has fabricated a polymeric-metallic hybrid biodegradable porous 
scaffold made of PCL and magnesium (Mg) micro-particles in order to facilitate bony in-
growth after implantation. This paper reports the mechanical, in vitro and in vivo 
properties of the newly developed scaffold. 
 
METHODS: Commercially available magnesium particles in micron size (i.e 45 ?m and 
150 ?m) (International Laboratory, USA) and polycaprolactone (PCL) (Sigma-Aldich, 
USA) with the average molecular weight of Mn ~ 80,000 g/mol were used for the 
scaffold fabrication. Silane coupling agent, 3-(Trimethoxysilyl) propyl methacrylate 
(TMSPM) (Sigma, USA) was used to coat on the surface of Mg particles in order to 
enhance the bonding between PCL and Mg. The treatment parameters and the 
characterization of the silane coating were reported in our previous study [3]. Salt 
leaching technique was used for the scaffold fabrication in which 7 g of sodium chloride 
(NaCl) were added and mixed with polymer slurry thoroughly. Finally, the samples were 
immersed into sodium hydroxide (NaOH) solution to allow the NaCl to leach out in order 
to obtain porous structure. The surface morphology of the fabricated scaffolds was 
examined by scanning electron microscopy and the porosity of the scaffolds was 
analyzed by using micro-computed tomography (Micro-CT) analysis. The compression 
modulus was examined by Materials Testing System according to the ASTM D695-08 
protocol. The samples were cultured with mouse MC3T3-E1 pre-osteoblasts for 3 days 
and their cytotoxicity was determined by standard MTT assay. The cell morphology was 
also examined by using fluorescent microscopy. To determine the bioactivity of the 
scaffolds, all the samples were immersed into DMEM culture medium for 7 days. Then, 
the scaffolds were viewed and examined under scanning electron microscopy and the 
surface composition was analyzed by energy-dispersive X-ray spectroscopy. In the 
animal testing, the scaffolds were implanted to the lateral epicondyle of femur of 2-month 
old female Sprague-Dawley rats (SD rats) for 3 months. Bone biopsies were harvested 
after 3 months. The histological slides were prepared and stained with Giemsa. The bony 
in-growth and the integration of implant-to-bone were then examined under optical 
microscopy. 
 
RESULTS: The pore size of all the scaffolds ranged from 200 ?m to 500 ?m and the 
porosity was found to be approximately 74 %. The compressive modulus of the pure PCL 
scaffold was found to be 0.4 MPa, whereas the compressive moduli of the 45 ?m and 
150 ?m Mg micro-particles incorporated scaffolds increased to 1 MPa and 1.4 MPa, 
respectively (Fig. 1). Furthermore, the compressive modulus of the 150 ?m Mg/PCL 
silane coupled scaffold almost doubled to 2.2 MPa as compared with the scaffold without 
the silane coupling treatment. With respect to the results of in vitro testing, the cell 
viability was significantly higher in all the Mg incorporated scaffolds as compared with 
the pure PCL scaffold (Fig. 2). This result suggested that the release of Mg ions upon 
degradation was able to enhance the viability of pre-osteoblasts. No significant difference 
of cell viability was found before and after silane coupling treatment. This result 
hopefully suggested that the silane coating on Mg micro-particles did not jeopardize the 
cyto-compatibility of the hybrid scaffold, while the mechanical property enhanced. In the 
bioactivity test, an apatite layer composed of calcium (Ca) and phosphate (P) was found 
on the Mg/PCL scaffolds, whereas pure PCL porous scaffold did not convince any 
formation of apatite layer. Referring to the in vivo testing results, all the scaffolds already 
degraded and new bone formation was observed within the porous structure and also 
adjacent to the scaffolds after 3-month implantation. No sign of inflammation was 
observed in both pure PCL and Mg/PCL scaffolds. High amount of newly formed bony 
tissue was observed in the silane-coupled Mg/PCL hybrid porous scaffolds as compared 
with the pure PCL porous scaffolds. This observation demonstrated that the pores within 
the scaffolds were interconnected such that bony tissue could grow into the scaffolds. 
 
DISCUSSION: Previous studies proposed that the presence of magnesium was able to 
enhance cell adhesion and also stimulated bone growth and bone healing [4]. The current 
in vitro results were consistent to our previous studies in which specific amount of Mg 
ions released was able to stimulate cellular activity [3]. The presence of Mg micro-
particles could improve the overall cellular activity of PCL/Mg scaffold thereof. In the in 
vivo testing, high amount of new bone formation in the PCL/Mg hybrid porous scaffold 
was also found. These observations may further prove that the bone forming ability of 
biomaterials can be enhanced by the controlled release of magnesium ions in vivo. Indeed, 
the literatures reported that the presence of magnesium in the bone system was beneficial 
to bone growth and also played a key role in bone remodeling and skeletal development 
[5]. However, the amount of Mg ions released is critical for bone formation [6], as too 
much Mg ions released would lead to bone loss. Hence, in addition to the improvement 
of mechanical properties of those scaffolds, the amount of Mg micro-particles 
incorporated into the scaffolds should be carefully controlled so as to avoid any adverse 
biological effect due to over release of magnesium ions [7]. 
 
SIGNIFICANCE: The incorporation of the magnesium micro-particles to pure PCL 
porous scaffold is able to improve its poor mechanical properties and inferior bioactivity. The 
controlled released of Mg ions can significantly enhance the bone formation ability of 
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